Evicenter
MarkdownMedical informationP&T meetings
Lanifibranor (IVA337)

Metabolic dysfunction-associated steatohepatitis with F2 to F3 fibrosis

Manufacturer
Inventiva
Last updated
220 sources

Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care

Lifestyle intervention and weight loss

8 evidence topics · 7 sources

EASL-EASD-EASO guideline recommendations: weight loss targets, diet quality, and physical activity in adults with MASLD